We are monitoring the impact of COVID-19 on North America Anti-neoplastic Agents Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 8047
Share on
Share on

North America Anti-neoplastic Agents Market Research Report – Segmented By Product Type, End User & Country (the United States, Canada and Rest of North America) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 8047
Pages: 145

The size of the North American Anti-neoplastic Agents Market is estimated to grow at a promising rate between 2021 to 2026.

Anti-neoplastic Agents are the first line of treatment for cancer. A variety of antineoplastics are available in the market and many drugs are still in the clinical phase. Cancer is becoming a major cause of death all over the world.

The rising number of people being diagnosed with cancer and the demand for affordable treatments for the same are the major drivers driving the market growth. Due to the recent advancements in personalized medicines the market is expected to propel during the forecast period. However, the high manufacturing costs of anti-neoplastic agents is the major factor hampering the market growth.

The market for Anti-neoplastic Agents is broadly categorized into product type and end user. By product type the market is divided into personalised medicine, biological agents and chemotherapeutic agents. Chemotherapeutic agents account for a major share of the market revenue. By end user the market is segmented into hospitals, clinics, cancer rehabilitation centres and ambulatory surgical centres. Hospitals segment dominated a major share of the market revenue. On the basis of geography, the market is analysed under various regions namely U.S.A and Canada. The Anti-neoplastic Agents market was dominated by North America.

Some of the major companies dominating the market, by their products and services include Aspen Global Inc., Bayer AG, Teva pharmaceutical Industries Ltd., Johnson & Johnson Pvt. Ltd., Merc & Co., Inc., Pfize Inc., Hoffmann-La Roche Ltd., Amgen Inc., Bristol-Myers Squibb Company, Baxter Healthcare Corporation, Boehringer Ingelheim GmbH, Accord Healthcare, Inc., Genentech, Inc., Lundbeck LLC, AbbVie Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Chemotherapeutic agent 

                                5.1.3 Biological agents   

                                5.1.4 Personalied medicine         

                                5.1.5  Y-o-Y Growth Analysis, By Product              

                                5.1.6  Market Attractiveness Analysis, By Product            

                                5.1.7  Market Share Analysis, By Product              

                5.2 End user                      

                                5.2.1 Introduction           

                                5.2.2 Hospitals  

                                5.2.3 Clinics        

                                5.2.4 Cancer rehabilitaion centers            

                                5.2.5 Ambulatory surgical centers            

                                5.2.6 Y-o-Y Growth Analysis, By end user             

                                5.2.7 Market Attractiveness Analysis, By end user           

                                5.2.8 Market Share Analysis, By end user             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By end user

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By end user

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By end user

                6.2 United States                            

                6.3 Canada                         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Hoffmann-La Roche Ltd                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Amgen Inc.                 

                8.3 Bristol-Myers Squibb Company                         

                8.4 Baxter Healthcare Corporation                          

                8.5 Boehringer Ingelheim GmbH                              

                8.6 Aspen Global Inc.                     

                8.7 Bayer AG                     

                8.8 Teva pharmaceutical Industries Ltd.                

                8.9 Johnson & Johnson Pvt. Ltd.                               

                8.10 Accord Healthcare, Inc.                       

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product Type, by End user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. North America Anti-neoplastic agents Market, By Product, From 2021 to 2026 (USD Billion)
  2. North America Chemotherapeutic agents Market, By Region, From 2021 to 2026 (USD Billion)
  3. North America Biological agents Market, By Region, From 2021 to 2026 (USD Billion)
  4. North America Personalised medicine Market, By Region, From 2021 to 2026 (USD Billion)
  5. North America Anti-neoplastic agents Market, By End user, From 2021 to 2026 (USD Billion)
  6. North America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  7. North America Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  8. North America Cancer rehabilitation centers Market, By Region, From 2021 to 2026 (USD Billion)
  9. North America Ambulatory surgical centers Market, By Region, From 2021 to 2026 (USD Billion)
  10. United States Anti-neoplastic agents Market, By Product, From 2021 to 2026 (USD Billion)
  11. United States Anti-neoplastic agents Market, By End user, From 2021 to 2026 (USD Billion)
  12. Canada Anti-neoplastic agents Market, By Product, From 2021 to 2026 (USD Billion)
  13. Canada Anti-neoplastic agents Market, By End user, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample